INCOME/LOSS PER SHARE |
INCOME/LOSS PER SHARE The following table presents the calculation of basic and diluted income/loss per share of common stock: | | | | | | | | | | | | | Three Months Ended March 31, | | 2022 | | 2021 | | (In thousands, except share and per share data) | Numerator: | | | | Net loss attributable to Acacia Research Corporation | $ | (73,266) | | | $ | (164,465) | | Dividend on Series A redeemable convertible preferred stock | (700) | | | (263) | | Accretion of Series A redeemable convertible preferred stock | (1,151) | | | (852) | | Undistributed earnings allocated to participating securities | — | | | 29,068 | | Net loss attributable to common stockholders - Basic and Diluted | $ | (75,117) | | | $ | (136,512) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Denominator: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Weighted average shares used in computing net loss per share attributable to common stockholders - Basic and Diluted | 46,544,313 | | | 48,596,040 | | | | | | Basic and diluted net loss per common share | $ | (1.61) | | | $ | (2.81) | | | | | | | | | | Anti-dilutive potential common shares excluded from the computation of diluted net loss per common share: | | | | Equity-based incentive awards | 4,029,318 | | | 2,100,391 | | Series A warrants | 5,000,000 | | | 5,000,000 | | Series B warrants | 100,000,000 | | | 100,000,000 | | Total | 109,029,318 | | | 107,100,391 | |
|